Search clinical trials for: LJPC-501
Total 4015 results
-
La Jolla Pharmaceutical CompanyTerminatedHepatorenal Syndrome Type I and Type IIUnited States
-
La Jolla Pharmaceutical CompanyApproved for marketingSepsis | Vasodilatory Shock | Distributive Shock | High Output Shock | Catecholamine Resistant Hypotension (CRH)
-
La Jolla Pharmaceutical CompanyCompletedSepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockUnited States, Canada, Belgium, Australia, United Kingdom, Finland, New Zealand, France, Switzerland, Germany
-
La Jolla Pharmaceutical CompanyTerminatedBeta-ThalassemiaAustralia, Thailand, United States, Greece, Italy, Lebanon, Turkey, United Kingdom
-
La Jolla Pharmaceutical CompanyPRA Health SciencesCompletedHereditary HemochromatosisUnited States, Australia, France, United Kingdom
-
Terns, Inc.Completed
-
NewG Lab PharmaActive, not recruitingHepatocellular Carcinoma | Fibrolamellar CarcinomaKorea, Republic of
-
La Jolla Pharmaceutical CompanyRecruitingSeptic Shock | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockBelgium, Lithuania
-
BiondVax Pharmaceuticals ltd.Completed
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...TerminatedRenal Cell Carcinoma | Hepatocellular CarcinomaAustralia, New Zealand
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
EGEN, Inc.Terminated
-
Bellicum PharmaceuticalsActive, not recruitingLymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
BiondVax Pharmaceuticals ltd.Completed
-
Cryonove PharmaCEISO; Dermatech; LTD HEALTHCompleted
-
Cryonove PharmaCEISO; Dermatech; Sefako Makgatho Health Sciences UniversityCompletedSolar Lentigo | Post-inflammatory Hyperpigmentation | Senile LentigoSouth Africa
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum PharmaceuticalsWithdrawnRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic... and other conditionsUnited States
-
Dermavant Sciences GmbHCompletedAtopic DermatitisCanada, United States
-
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.Active, not recruitingMajor Depressive DisorderUnited States
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
University of California, Los AngelesCompleted
-
SensorionNot yet recruitingOtorhinolaryngologic Diseases | Ear Diseases | Hearing Disorders | Deafness | Hearing Loss, Sensorineural | Congenital Deafness | DFNB9 | OTOF Gene MutationFrance
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedLiver DysfunctionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Amicus TherapeuticsActive, not recruitingBatten Disease | CLN6United States
-
Chong Kun Dang PharmaceuticalCompletedHealthy | Renal ImpairmentKorea, Republic of
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaTaiwan, Korea, Republic of, Japan
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Beacon TherapeuticsEnrolling by invitationX-Linked Retinitis PigmentosaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingFatigue | Weight Loss | Fever | Splenomegaly | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...CompletedSolid Tumor | Microsatellite Instability | Mismatch Repair Deficiency | Cancer of Unknown Primary SiteAustralia
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedIschemic Optic Neuropathy/Optic Nerve StrokeUnited States
-
Medigen Vaccine Biologics Corp.CompletedH7N9 Influenza VaccineTaiwan
-
Stanford UniversityRecruitingGlaucomaUnited States
-
Bellicum PharmaceuticalsActive, not recruitingLymphoma | Myelodysplastic Syndromes | Leukemia | Hematologic Neoplasms | Multiple MyelomaUnited States
-
Bellicum PharmaceuticalsTerminatedHemoglobinopathies | Hemophagocytic Lymphohistiocytosis | Metabolic Disorders | Primary Immune Deficiency Disorders | Inherited Bone Marrow Failure SyndromeUnited States
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedCompletedMacular Telangiectasia Type 2United States, Australia
-
Bellicum PharmaceuticalsWithdrawnHematologic MalignanciesUnited States
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Jeffrey L GoldbergCompletedGlaucoma, Primary Open AngleUnited States
-
Rapa Therapeutics LLCHackensack Meridian HealthTerminated